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INTRODUCTION 
Systemic administration of yohimbine, an alpha-2 
adrenergic antagonist, facilitates the copulatory 
behaviors of male rats. This facilitation has been 
interpreted as an increase in sexual motivation, as 
indexed by (a) increased mounting behavior following 
penile anesthetization, (b) increased copulatory 
performance in sexually inexperienced rats, (c) 
induction of copulation in sexually inactive rats, (d) 
enhancement of copulatory behaviors in castrated rats 
and (e) aged rats (Clark, Smith & Davidson, 1984, 
1985a, 1985b; Smith & Davidson, 1990; see Appendix A 
for a discussion of pharmacological manipulations of 
copulatory behaviors). 
Peters and associates (Koch & Peters, 1987; 
Peters, 1983; Peters, Blythe, Koch, & Kueker, 1989; 
also, see Lawrence & Kiefer, 1987) have described a 
copulation-illness association (C-IA) paradigm in which 
male rats receive lithium chloride (LiCl) after each of 
several copulatory opportunities. LiCl induces 
aversive interoceptive consequences and is commonly 
used to establish conditioned taste aversions in a 
single trial (Garcia & Koelling, 1966). The copulatory 
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behaviors of male rats are associatively inhibited in 
the C-IA paradigm, albeit at a slower rate (5-10 
trials). Peters, Koch, and Blythe (1988) reported that 
male rats treated with yohimbine were more likely to 
copulate during both C-IA acquisition and extinction. 
The facilitory effects of yohimbine on sexual 
behavior have been attributed to an increase in sexual 
motivation (Clark et al., 1984). The effects of 
yohimbine on copulatory behaviors in the C-IA paradigm 
are consistent with this interpretation. The 
inhibition of copulatory behaviors in this paradigm, 
however, reflects an associative process. Yohimbine's 
facilitation of copulatory behaviors in the C-IA 
paradigm could conceivably reflect an influence on 
associative mechanisms rather than a more direct 
activation of copulatory behaviors. Thus, the 
facilitation of copulatory behavior during C-IA 
acquisition may reflect yohimbine's disruption of an 
associative mechanism. Counter to this interpretation, 
however, are yohimbine's facilitory effects on 
copulatory behaviors during C-IA extinction (Peters et 
al., 1988). To the extent that both acquisition and 
extinction involve the formation of associative 
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connections (Rescorla, 1979), it is unlikely that 
yohimbine disrupts an associative mechanism during 
acquisition and facilitates an associative mechanism 
during extinction. 
The purpose of the present experiments is to 
further characterize the effects of yohimbine on 
copulatory behaviors. Prior research (Bowes, 1990) 
examined the hypothesis that the effects of yohimbine 
on copulatory behavior may reflect an increase in 
activity level, making any behavior, including 
copulatory behavior, more likely. Yohimbine, however, 
significantly reduced activity suggesting that the 
facilitory effects of yohimbine on copulatory behavior 
are not mediated by an increase in general activity 
level. 
If yohimbine's facilitation of copulatory 
behaviors in the C-IA paradigm reflects an increase in 
sexual motivation, significant differences in 
copulatory behaviors would be anticipated on first 
trial comparisons of yohimbine and control groups, 
prior to associative inhibition of copulation. 
Yohimbine's facilitation, however, is not evident until 
the third or fourth acquisition trial (Peters et al.. 
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1988; Bowes, 1990). During these trials, after C-IA 
suppression of copulatory behaviors, male rats treated 
with yohimbine had shorter intromission and ejaculation 
latencies, as well as a higher probability of 
ejaculation. If yohimbine increases sexual motivation, 
why is this effect not evident on the first test trial? 
One possibility is that during initial trials, high 
baseline levels of copulatory behaviors cannot be 
further enhanced by yohimbine. Yohimbine's facilitory 
effects may be observable only when copulatory 
behaviors occur at less than a maximal rate. These 
circumstances prevail following several acquisition 
trials in the C-IA paradigm. Similarly, the facilitory 
effects of yohimbine have been demonstrated when 
copulatory behaviors are inhibited by castration, 
penile anesthetization, sexual inexperience, age, and 
in rats that do not spontaneously initiate copulatory 
behaviors (sexually "sluggish" rats; Clark et al., 
1984, 1985a, 1985b; Smith & Davidson, 1990). 
An alternative explanation for the lack of 
yohimbine's facilitation of copulatory behaviors on 
initial trials is that habituation to the effects of 
yohimbine is necessary before facilitation may be 
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observed. On the first few trials the physiological 
state produced by yohimbine may interfere with the 
facilitory effect of the drug. After repeated 
exposures, animals may habituate to this initial 
physiological state. Consistent with this hypothesis, 
data from this laboratory suggest that a higher dose of 
yohimbine (4.0 mg/kg) significantly disrupted 
copulatory behavior on the first trial yet facilitated 
sexual behavior during later test sessions (Bowes, 
1990). 
Noradrenergic mechanisms have been implicated in 
the regulation of "vigilance", or sensitivity to 
environmental stimuli (Aston-Jones, 1985). Yohimbine, 
an alpha-2 adrenergic antagonist, increases brain 
norepinephrine (NE) levels, presumably by autoreceptor 
blockade. Neural activity of NE neurons of the locus 
coeruleus decreases during periods of grooming or 
ingestive behavior (Aston-Jones & Bloom, 1981a, 1981b). 
Increased NE levels may initially produce a state of 
heightened vigilance and decreased activity, a state 
inconsistent with the performance of copulatory 
behaviors. Habituation of this state of heightened 
vigilance may be prerequisite to yohimbine's facilitory 
6 
effect on copulatory behaviors. Yohimbine's reduction 




Yohimbine (2.0 mg/kg) facilitates copulatory 
behavior in the C-IA paradigm (Peters et al., 1988). 
As noted above, this facilitory effect is not evident 
on initial test trials but rather, after two or more 
acquisition trials. This lack of facilitation of 
sexual behavior may reflect a ceiling effect produced 
by high baseline levels of copulatory behaviors 
(intromission latencies on these first trials are often 
10 seconds or less). Alternatively, the physiological 
state induced by yohimbine may initially attenuate 
yohimbine's facilitory effect on copulatory behaviors. 
In this case, habituation to some of the drug's effects 
may be necessary before facilitation is observed. 
In this experiment the effects of yohimbine on 
copulatory behaviors were examined using a modification 
of the C-IA procedure. The copulatory behaviors of all 
subjects were partially inhibited prior to the 
comparison of the effects of yohimbine and saline 
groups on copulatory behaviors. Male rats display a 
large range of intromission latencies during their 
first encounter with an estrous female. Upon a second 
encounter, this range is considerably reduced with 
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briefer latencies (10-100 sec) observed for most 
animals. Post-trial LiCl administration began after 
the second pairing with an estrous female. Rather than 
initiating pre-trial administration of yohimbine on the 
following trial, before the third pairing with an 
estrous female (when intromission latencies are brief 
following only one copulation-illness pairing), 
yohimbine was not administered until the animal's 
intromission latency exceeded its briefest intromission 
latency by 100 sec. Yohimbine was then administered 
prior to the next pairing with an estrous female for 
half of the subjects; the other half received saline. 
In addition, the possible effects of experience 
with yohimbine outside of the context of the copulation 
test were examined. Half of the subjects in each of 
the groups described above received yohimbine 24 hr 
following each copulation test. Thus, these animals 
received 2-5 intertriai yohimbine injections; the 
others received saline. The experimental design was 
thus a 2 X 2 factorial with prior drug experience 
(intertriai yohimbine vs. saline) and pre-trial drug 
groups (yohimbine vs. saline) as the two factors. 
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The following drug effects were predicted. If 
yohimbine's failure to facilitate copulatory behaviors 
on initial C-IA trials reflects a ceiling effect due to 
high baseline levels of copulatory behaviors, then the 
yohimbine-treated animals should have significantly 
shorter mount and intromission latencies than the 
saline group on the first test trial when copulation is 
partially inhibited. If yohimbine produces a novel 
state requiring habituation before facilitation of 
copulatory behaviors is possible, then significantly 
reduced mount and intromission latencies would be 
expected for the subjects receiving intertriai 
yohimbine. Additionally, the yohimbine effects 
observed in the C-IA procedure may reflect only the 
result of repeated yohimbine exposure and may not 
depend on yohimbine administration at test. If 
yohimbine facilitates copulatory behaviors as a result 
of repeated exposure alone, then animals receiving 
intertriai yohimbine, when administered saline at test, 
should exhibit increased copulatory behaviors relative 
to the saline/saline control group. In other words, a 
significant intertriai by test trial interaction would 
indicate the possibility that the important variable in 
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yohimbine's facilitory effects on copulatory behavior 
in the C-IA paradigm is repeated exposure to yohimbine 
alone, independent of drug administered during the 
copulation test. 
Method 
Subjects. Male and female Sprague-Dawley albino 
rats were obtained at 22-25 days of age from Laboratory 
Animal Resources, College of Veterinary Medicine, Iowa 
State University. Animals were housed in groups of 5-
6 until the beginning of the experiment and were 
individually housed thereafter. Subjects were housed 
in a temperature-controlled environment (22-24° C) and 
maintained on a reversed 12:12 hr light/dark cycle with 
lights off at 0800. Food (Simonsen 1526 rat/mice diet) 
and water were available ad lib except during testing. 
Behavioral testing began when the rats were 80-90 days 
of age. 
Stimulus females. Ovariectomies were performed 
using ketamine (80 mg/kg) and xylazine (12 mg/kg) 
anesthesia, at least one week prior to test sessions. 
Estrus was induced with estradiol benzoate (5 ug sc, 48 
and 24 hr before test sessions) in a 0.1 ml sesame oil 
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vehicle. Females were screened for sexual receptivity 
with sexually vigorous nonexperimental males prior to 
each behavioral test session. Only females displaying 
proceptive behaviors (Beach, 1976) in addition to 
vigorous lordosis were used in this experiment. 
Apparatus. Nine test compartments were each 74 X 
56 X 38 cm with inside walls painted black. Glass on 
the front wall allowed viewing of copulatory activity. 
Chambers were insulated on all sides except the viewing 
wall with 2.54 cm styrofoam to minimize sound 
transmission. Each chamber was dimly illuminated from 
above with a 15 W red light bulb, and ventilated with 
an exhaust fan. 
Drugs used were yohimbine hydrochloride (Sigma 
Chemical Company, St. Louis) and isotonic saline. 
Yohimbine was dissolved in distilled water prior to 
each test session. 
Procedure. Copulation tests were conducted at 3-
4 day intervals during the middle third of the dark 
cycle in an observation room dimly illuminated with red 
light. For all copulation tests, each male was placed 
in the test compartment for 1-2 min prior to 
introduction of the female. Behavioral data collected 
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were the intervals between introduction of the female 
and the first mount (mount latency or ML), intromission 
(IL) and ejaculation (EL), as well as mount and 
intromission frequency. 
Following an initial screening for copulatory 
activity, male rats were assigned to one of two groups. 
During acquisition of criterion IL (see below), half of 
the subjects received intertriai injections (saline 1 
ml/kg ip, or yohimbine 2.0 mg/ml/kg ip) 24 hr following 
each acquisition session. As each animal attained the 
partial inhibition criterion it was randomly assigned 
to one of the two groups receiving yohimbine (2.0 mg/kg 
ip) or isotonic saline (1 ml/kg ip) 20 min prior to the 
next test session for that animal. There were thus 
four combinations (n = 8 per group) of drug condition 
and prior experience; saline (saline vs. yohimbine 
intertriai administration) and yohimbine (saline vs. 
yohimbine intertriai administration). 
Copulatory behaviors were partially inhibited 
prior to the drug administration trial. Animals 
received a variable number of acquisition trials until 
the animal's IL exceeded its shortest IL by at least 
100 sec; the next trial was the copulation test trial 
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for that animal. Thus, on any given experimental 
session, some animals would receive acquisition trials 
and some test trials. Each session was terminated with 
either an ejaculation, failure to intromit within 900 
sec, or failure to ejaculate within 1800 sec. Each 
male was paired with a different female and tested in a 
different test compartment on each test session. Males 
were injected with LiCl (0.3 M, 20 ml/kg) within 1 min 
of termination of each acquisition trial and were 
returned to the home cage. 
The trial following acquisition of the partial 
inhibition criterion was the drug trial for each 
subject. Twenty min prior to this test session animals 
received an injection of either yohimbine (2.0 mg/kg 
ip) or saline (1 ml/kg ip). 
Results. 
An average of 3.8 copulation-illness pairings 
preceded acquisition of criterion intromission latency. 
The mean number of trials required to attain the 
criterion intromission latency was approximately equal 
for the four groups. 
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Pretrial administration of yohimbine did not 
significantly affect any measure of copulatory behavior 
in animals with partially inhibited copulatory 
behaviors (see Figure 1). Intertriai exposure to 
yohimbine also did not increase copulatory behavior, 
nor was the intertriai x pretrial interaction 
significant for any measure of copulatory behavior (ML, 
IL, mount frequency, intromission frequency). A power 
analysis was conducted to estimate the number of 
subjects required to detect a difference between groups 
due to pretrial and intertriai yohimbine 
administration. Standard deviations for the pretrial 
and intertriai main effects were 345 and 373, 
respectively. With a power of .90 and an effect size 
of one-half standard deviation, the required number of 
subjects was approximately 11, in good agreement with 
the main-effect group sizes of 16 in this experiment. 
The lack of significant differences between groups does 
not appear to reflect merely a lack of experimental 
sensitivity. 
A separate analysis was conducted on the data from 
the drug test trial and the two preceding acquisition 
trials to confirm that there were no group differences 
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prior to the drug test trial. A 3-way ANOVA with two 
between-subjects factors (intertriai drug and test 
trial drug) and one within-subjects factor (acquisition 
trials) was conducted. Copulatory behavior declined 
over the three trials, with significant increases in ML 
and IL (es <.0001). No between-group differences were 
observed on the trials preceding the test trial, nor 
were the intertriai, test trial or acquisition trial 
interaction effects significant. 
Discussion. 
This experiment evaluated the effects of yohimbine 
on the copulatory behaviors of male rats when these 
behaviors had been partially inhibited by copulation-
illness associations. Yohimbine did not significantly 
facilitate any measure of copulatory behavior in this 
experiment. This finding suggests that the failure of 
yohimbine to facilitate copulatory behaviors can not be 
attributed to high baseline levels of copulatory 
behaviors. 
In addition to the partial inhibition procedure, 
the effects of intertriai yohimbine exposure were 
examined. Intertriai yohimbine exposure did not 
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facilitate copulatory behaviors in this experiment. It 
is possible that yohimbine exposure is effective only 
within the context of the copulation test. In this 
experiment, intertriai yohimbine exposure occurred in 
the home cage. A more appropriate pre-exposure 
procedure may involve a series of copulation tests in 
which yohimbine is administered, prior to C-IA 
acquisition. In this situation the stimulus 
characteristics of drug experience setting and drug 
test setting are more similar. Substantial evidence 
documents that context plays an important role in 
habituation to drug response and that dissimilarities 
between the habituation environment and test 
environment may attenuate habituation to drug effects 
(Siegel, 1988; Siegel, Hinson, Krank, & McCully, 1982). 
Yohimbine failed to potentiate copulatory 
behaviors when first administration followed either C-
lA acquisition or intertriai experience with the drug. 
This outcome is not consistent with an activational 
interpretation of yohimbine's effects in the C-IA 
paradigm. This also suggests that the effects of 
yohimbine on copulatory behaviors in this paradigm may 
reflect yohimbine's effects on an associative 
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mechanism. This possibility could be evaluated using 
the C-IA procedure with the modification that the test 
trials following partial inhibition would also serve as 
additional acquisition trials. These trials would be 
followed by LiCl administration. A gradual divergence 
of these groups would suggest interference with an 
associative mechanism. This modification was not 
performed in this experiment because it was felt that a 
large number of animals would quickly attain criterion 
mount and intromission latency. 
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EXPERIMENT 2 
Yohimbine, an alpha-2 adrenergic antagonist, 
facilitates copulatory behaviors in the C-IA paradigm 
(Peters et al., 1988; Bowes, 1990). Naloxone, an 
opiate antagonist that facilitates copulatory behaviors 
in other test settings (Gessa, Paglietti, & Pellegrini-
Quarantotti, 1979; Rhees, Badger, & Fleming, 1983) 
inhibits copulation in the C-IA paradigm (Peters et 
al., 1988). It is therefore important to determine if 
other pharmacological manipulations known to facilitate 
sexual behavior in various paradigms similarly increase 
copulatory behaviors in the C-IA paradigm. 
The purpose of this experiment was to evaluate, 
using the C-IA paradigm, the effects of a 
pharmacological manipulation (apomorphine) known to 
facilitate copulatory behaviors. Dopamine agonists 
(e.g., apomorphine) facilitate copulatory behaviors in 
male rats (Argiolas, Collu, D'Aquila, Gessa, Melis & 
Serra, 1989; Malmnas, 1973; Paglietti, Quarantotti, 
Mereu, & Gessa, 1978; Pehek, Thompson & Hull, 1989; 
Tagliamonte, Fratta, Del Fiacco & Gessa, 1974) and 
Rhesus monkeys (Pomerantz, 1990; see Appendix A). 
Three doses of apomorphine were selected from the broad 
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range of dose levels that facilitate copulatory 
behaviors in other experimental settings. 
Method. 
Subjects. Forty Sprague-Dawley albino rats were 
housed under the conditions described in Experiment 1. 
Apparatus. The apparatus was the same apparatus 
as used in Experiment 1. Apomorphine (Sigma chemical 
company) was dissolved in sterile saline containing 2 
mg/ml ascorbic acid and was prepared before each test 
session. 
Procedure. Following an initial screening trial 
for copulatory activity, male rats were assigned to one 
of four conditions. Fifteen min prior to each C-IA 
acquisition trial animals received an ip injection of 
ascorbic acid vehicle (1 ml/kg) or apomorphine (150, 
300, or 450 ug/ml/kg). Each test session was 
terminated after either an ejaculation, a failure to 
intromit within 900 sec, or a failure to ejaculate 
within 1800 sec. Each male was paired with a different 
female and tested in a different test compartment on 
each acquisition trial. Data were collected from a 
total of seven sessions; one initial screening trial 
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for sexual activity, the initial acquisition trial, and 
5 test trials. Each male was injected with LiCl (0.3 
M, 20 ml/kg ip) within 1 min of termination of each 
acquisition session and was returned to its home cage. 
Data for the first two trials (screening and 
initial acquisition trial) were analyzed separately. 
Variables of interest were the latency to first mount 
(ML), intromission (IL) and ejaculation (EL) as well as 
mount and intromission frequency. Variables were 
examined using one-way analysis of variance on these 
initial trials. On test trials EL was not analyzed due 
to the large number of animals failing to ejaculate 
during C-IA acquisition. Data from these trials were 
analyzed as a two-way ANOVA with repeated measures, one 
within-groups factor (trials) and one between groups 
factor (drug group). 
Following C-IA acquisition, a series of four 
extinction trials was conducted. Only subjects 
attaining the 900 sec intromission latency criterion on 
the preceding acquisition trial were included in the 
extinction trial series. Twenty-three subjects were 
randomly assigned to vehicle or apomorphine (150 ug/kg) 
conditions with the constraint that the number of 
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subjects in each group should contain, as closely as 
possible, equal numbers of subjects from each of the 
four C-IÀ acquisition conditions. The apomorphine dose 
(150 ug/kg) was selected on the basis of the 
acquisition trials data. This was the only dose that 
provided any indication of facilitation of copulatory 
behaviors during C-IÀ acquisition. Copulation tests 
were conducted as described above with the exception 
that LiCl was not administered. Subjects were injected 
with either saline or apomorphine 15 min prior to 
copulation test. 
Results. 
Administration of apomorphine (150, 300, & 450 
ug/ml/kg) did not significantly increase copulatory 
behaviors during C-IA acquisition (see Figure 2). No 
significant differences were observed among groups for 
either the screening trial or the initial acquisition 
trial (first exposure to apomorphine preceding LiCl 
exposure). 
During C-IA acquisition, copulatory behaviors 
gradually declined following repeated pairings of LiCl 
with copulatory opportunities as evidenced by increased 
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mount latency (ML) [F(4,140)=18.85, g<.0001] and 
intromission latency (IL) [F(4,140)=16.35, gK.OOOl]. 
Mount and intromission frequencies significantly 
declined during C-IA acquisition trials (gs <.001). No 
significant drug effects were observed for any of these 
measures, nor were the drug x trial interactions 
significant. 
An examination of Figure 2 indicated that the 
apomorphine 150 ug/kg dose was the only dose that 
provided any indication of facilitation of copulatory 
behavior. This dose was selected for extinction 
trials. During C-IA extinction, animals gradually 
resumed copulatory behaviors as evidenced by reduced 
MLs and ILs (gs <.01) as well as increased mount 
frequency (ES<.001). Apomorphine facilitated 
copulatory behavior during C-IA extinction as evidenced 
by reduced latency to mount and intromit in 
apomorphine-treated animals (ES<.03) (see Fig. 3). 
Discussion. 
In this experiment the effects of apomorphine, a 
dopamine agonist known to facilitate copulatory 
behaviors, were examined. Copulatory behaviors were 
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gradually inhibited during C-IA acquisition. 
Apomorphine failed to facilitate copulatory behavior 
during C-IA acquisition, but the 150 ug/kg dose 
increased copulatory behavior during C-IA extinction. 
This may reflect the fact that group sizes were larger 
in extinction than acquisition (12-13 vs. 9-10). There 
were, however, more trials during C-IA acquisition and 
therefore more statistical power using this repeated-
measures design. The failure of apomorphine to 
facilitate copulatory behavior in C-IA acquisition 
contrasts with the effects of yohimbine, which has 
potentiated copulatory behavior in each of four 
experiments conducted in this laboratory. This finding 
may suggest that C-IA extinction is more sensitive to 
manipulations that increase copulatory behaviors than 
C-IA acquisition. 
In addition to its effects on sexual behavior, 
apomorphine also possesses emetic properties and is 
capable of supporting a conditioned taste aversion, 
albeit at dose levels greater than those employed in 
this study (Parker & Brosseau, 1990). It is possible, 
however, that the emetic effects of apomorphine 
interacted with those of LiCl and the resulting illness 
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facilitated C-IA acquisition, which would suppress 
copulatory behaviors. Naloxone also failed to 
facilitate copulatory behavior in this paradigm. 
Naloxone and apomorphine may both fail to facilitate 
copulatory behaviors in this paradigm by increasing the 
perceived aversiveness of LiCl; naloxone by blocking 
opiate receptors and apomorphine due to its emetic 
properties. Dopaminergic systems also participate in 
the regulation of reinforcement and learning (Fouriezos 
& Wise, 1974; Spryaki, Fibiger & Phillips, 1982). The 
potential emetic, learning and copulatory effects of 
apomorphine may interact in this paradigm in a manner 
not characteristic of other procedures assessing 
copulatory behaviors. The result of this interaction 
may be a yield of no net change in copulatory 
behaviors. 
An additional test of the utility of the C-IA 
paradigm as a procedure for evaluating manipulations 
facilitating copulation would be an examination of the 
effects of serotonin antagonists (e.g., p-
chlorophenylalanine, PCPA). PCPA increases male 
copulatory behavior (Ahlenius, Eriksson, Larsson, 
Modigh, & Sodersten, 1971; Ahlenius, Larsson, & 
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Svensson, 1980). An examination of PCPA in the C-IA 
paradigm would provide useful information regarding the 
appropriateness of this testing procedure for the 
examination of drugs facilitating copulatory behavior. 
26 
GENERAL DISCUSSION 
The purpose of the present experiments was to 
further characterize the effects of catecholaminergic 
manipulations on copulatory behaviors in the C-IA 
paradigm. Yohimbine did not facilitate copulatory 
behaviors on initial C-IA acquisition trials, even when 
copulatory behaviors had been previously partially 
inhibited, and the animals had prior experience with 
the drug. Apomorphine, a dopamine agonist known to 
facilitate copulatory behaviors, did not facilitate 
these behaviors during C-IA acquisition, although 
copulatory behaviors were significantly facilitated 
during C-IA extinction. It is possible that other 
effects of apomorphine (e.g., reinforcement and emetic) 
and yohimbine (e.g., vigilance) interact in this 
paradigm to prevent facilitation of copulation. 
In some respects, the C-IA procedure resembles the 
conditioned emotional response (CER) paradigm (Brush, 
1971). Briefly, this procedure involves pairing an 
electric shock with some stimulus, such as a light or 
tone presentation. Following several signal-shock 
pairings, barpressing in the presence of the signal is 
decreased. The CER procedure contrasts with punishment 
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procedures in that the shock is not preventable and is 
not contingent on any particular behavior. In the C-
lA procedure, animals are given LiCl regardless of 
whether they copulate. The presence of the female may 
serve as a signal. Following several pairings of the 
aversive contingency with the signal, a suppression of 
behavior results. 
Naloxone potentiates sexual behavior in some 
paradigms (Gessa et al., 1979; Rhees et al., 1983) but 
interferes with copulatory behaviors in the C-IA 
paradigm (Peters et al., 1988). Opiate antagonists 
such as naloxone potentiate CER acquisition (Gallagher, 
Kapp, McNall, & Pescoe, 1981), but do not increase 
sensitivity to pain when administered alone (Goldstein, 
Pryor, Otis, & Larsen, 1976; Rodgers, 1978). Thus, 
naloxone effects in the C-IA procedure parallelled 
those of the CER paradigm. It is possible that this 
paradigm is an extension of the CER paradigm, and that 
similar pharmacological manipulations of the two 
procedures may provide similar results. Thus, the 
effects of naloxone in the C-IA paradigm are consistent 
with the effects of naloxone in the CER paradigm, but 
not with its facilitation of copulatory behaviors. 
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In addition to its prosexual effects, yohimbine 
has been described as an anxiogenic substance (Huang, 
Messing & Sparber, 1987). Anxiolytics antagonize the 
suppression of behavior induced by CER training 
(Rawlins, Feldon, Salmon & Gray, 1980). Consequently, 
it would be anticipated that the anxiogenic properties 
of yohimbine would suppress copulatory behaviors in the 
C-IA paradigm. In actuality, yohimbine potentiates 
behavior in this paradigm. Thus, the effects of 
yohimbine more closely resemble those of an anxiolytic 
than an anxiogenic. 
Additional research is necessary in order to 
characterize the effects of catecholaminergic 
manipulations on copulatory behaviors. Yohimbine did 
not facilitate copulatory behavior despite prior 
experience with the drug. It is possible that the 
stimulus characteristics of the experience setting and 
drug test setting were too dissimilar. Thus, a better 
procedure may be to give subjects access to a receptive 
female following yohimbine administration for a few 
trials before C-IA acquisition begins. Additionally, 
other pharmacological manipulations expected to 
facilitate copulatory behavior should be examined. A 
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large number of substances facilitate sexual behaviors 
of male rats (see Appendix A). Additionally, the 
apomorphine doses presented may have been too high; a 
lower apomorphine dose may have facilitated copulatory 
behaviors. 
The C-IA paradigm demonstrates the importance of 
the interaction between a pharmacological manipulation 
and environmental contingencies in producing a 
behavioral response. Naloxone and apomorphine, known 
to facilitate sexual behavior in other paradigms, were 
ineffective in C-IA acquisition, demonstrating 
differential behavioral responding in test situations 
which do and do not contain aversive elements. 
Additionally, the lack of facilitation of copulatory 
behavior by yohimbine on initial test trials apparently 
does not reflect a ceiling effect due to high baseline 
levels of responding. 
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FIGURE CAPTIONS 
FIGURE 1. Effects of test trial treatment condition as 
a function of intertriai exposure. 
FIGURE 2. Mean mount latency for apomorphine- (150, 
300 and 450 ug/kg) and vehicle-treated rats during C-
lA acquisition. 
Figure 3. Mean mount latency for apomorphine- and 
vehicle-treated rats during C-IA extinction. 
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PHARMACOLOGICAL MANIPULATIONS OF MALE SEXUAL BEHAVIORS 
The purpose of this appendix is to provide a 
summary of pharmacological manipulations of male sexual 
behavior. A goal of this research has been to identify 
neurotransmitter systems that participate in the 
regulation of these behaviors. Male copulatory 
behaviors are regulated by complex interactions among 
the monoamine neurotransmitters, neuroactive peptides, 
and steroid hormones. This review will focus on neural 
modulation of copulatory behavior, specifically, the 
results of pharmacological manipulations of a number of 
neurochemical systems including dopamine, serotonin, 
norepinephrine, GABA, and neuroactive peptides. 
Dopmamineraic modulation af sexual behavior. 
Considerable evidence suggests that increased activity 
within dopaminergic systems facilitates copulatory 
behaviors. Tagliamonte, Fratta, del Fiacco, and Gessa 
(1974) reported that the dopamine synthesis precursor 
L-DOPA increased copulation in sexually sluggish rats 
(rats that do not initiate a copulatory sequence when 
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paired with a receptive female). L-DOPA increased the 
proportion of male rats copulating after castration and 
administration of subthreshold testosterone replacement 
(Malmnas, 1973; 1976). Paglietti, Pellegrini-
Quarantotti, Mereu, and Gessa (1978) reported that L-
DOPA decreased ejaculation latencies in sexually active 
male rats. L-DOPA also increased the percentage of 
males that ejaculated. Clinical data also suggest a 
facilitory role for dopamine in human sexual behavior. 
Male patients receiving L-DOPA for Parkinson's disease 
have reported increased sex drive and erectile ability 
(Barbeau, 1969; Benkert, Crombach, & Kockott, 1972; 
Bowers, van Woert, & Davis, 1971). 
Although suggestive, reports of copulatory 
facilitation by L-DOPA cannot be considered conclusive 
because high doses of L-DOPA interfere with male sexual 
behavior (Gray, Davis, & Dewsbury, 1974). It is 
possible, however, that this effect is mediated by an 
indirect effect on serotonin turnover. High levels of 
L-DOPA decrease brain serotonin and increase levels of 
5-HIAA, a serotonin metabolite (Bartholini, de Prada, & 
Pletscher, 1986; Hyppa, Lehtinen, & Rinne, 1971). 
Another possibility is that high levels of dopamine act 
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in the spinal cord to inhibit sexual behavior. Pehek, 
Thompson, and Hull (1989) reported that intrathecal 
administration of apomorphine (a dopamine agonist) 
inhibited penile reflexes. Effects of L-DOPA 
administration are also difficult to interpret because 
L-DOPA is the precursor for both norepinephrine and 
dopamine. Thus, the observed effects on sexual 
behavior could conceivably reflect increased 
norepinephrine synthesis, rather than an effect on 
dopamine neurotransmission. 
Additional evidence of dopaminergic regulation of 
male sexual behavior comes from an examination of the 
effects of dopamine receptor agonists and antagonists. 
Although the specificity of any substance for a certain 
population of receptors is only relative, evidence 
suggests that activation of central dopaminergic 
systems increases copulatory behavior. 
A number of studies have examined the effects of 
the dopamine receptor agonist apomorphine on measures 
of copulatory behavior. Tagliamonte et al., (1974) 
reported that apomorphine increased copulatory behavior 
of male rats with low baseline rates of sexual 
activity. The effect was prevented by haloperidol, a 
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dopamine receptor antagonist, suggesting that the 
effect of apomorphine was not the result of secondary 
modulation of another neurotransmitter system. The 
authors also reported, however, that apomorphine 
decreased copulatory behaviors in male rats with high 
baseline rates of sexual activity. Apomorphine 
reduced the number of penile intromissions preceding 
ejaculation in male rats (Paglietti et al., 1978). 
This facilitation was prevented by the dopamine 
receptor antagonist pimozide. Malmnas (1973) reported 
that apomorphine both increased the proportion of male 
rats displaying copulatory behaviors and decreased 
mount and intromission latency. Pomerantz (1990) 
described a facilitory effect of apomorphine on the 
copulatory behaviors of male Rhesus monkeys. In 
contrast, Chambers and Phoenix (1989) reported no 
significant facilitation of copulatory behavior in 
Rhesus monkeys, although the dose of apomorphine used 
in their study was considerably higher than that used 
by Pomerantz (1990; 150 vs. 50 ug/kg). 
Falaschi, Rocco, DeGiorgio, Frajese, Fratta, and 
Gessa (1981) evaluated the relative contributions of 
central versus peripheral dopamine receptors in the 
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modulation of copulatory behavior. Domperidone is a 
dopamine antagonist that does not cross the blood-
brain barrier. The facilitory effect of apomorphine on 
sexual behavior was prevented by haloperidol, but not 
by domperidone, suggesting that the effects of 
apomorphine on copulatory behaviors depend on 
activation of central, rather than peripheral, dopamine 
receptors. 
Anatomical studies also support the hypothesis 
that dopaminergic systems participate in activation of 
copulatory behaviors. Substantial evidence documents 
the importance of the nucleus accumbens in 
reinforcement (Guerin, Goeders, Dworkin, & Smith, 1984; 
Stellar, Kelley, & Corbett, 1983). Pleim, Matochik, 
Barfield and Auerbach (1990) reported elevated dopamine 
and DOPAC (a dopamine metabolite) in the nucleus 
accumbens during sexual behavior. Pehek, Warner, 
Bazzet, Bitran, Band, Eaton and Hull (1988) found that 
cis-flupenthixol. a dopamine antagonist, impaired 
copulation when injected into the medial preoptic area 
of male rats, a brain region implicated in regulation 
of male sexual behaviors (Hart & Leedy, 1985). 
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Although evidence suggests that dopaminergic 
systems participate in regulation of male sexual 
behavior, the specific mechanisms remain unclear. 
Apomorphine commonly facilitates copulatory behaviors 
at dose levels lower than those that produce 
hyperactivity, suggesting that apomorphine facilitates 
copulatory behavior by the selective activation of 
presynaptic autoreceptors (Bitran & Hull, 1987). The 
implication of this suggestion is that apomorphine's 
facilitation of copulatory behaviors is mediated by a 
reduction in dopamine activity. Additionally, drugs 
described as dopamine autoreceptor agonists (e.g., RDS-
127; but note that RDS-127 is also a agonist) 
reduce ejaculatory thresholds in sexually active male 
rats (Clark, Smith, Stefanick, Arneric, Long, & 
Davidson, 1982; Clark, Stefanick, Smith, & Davidson, 
1983). Conversely, studies of the drug 3-PPP have not 
supported the autoreceptor stimulation hypothesis. 
(-)3-PPP is an autoreceptor agonist and postsynaptic 
receptor antagonist whereas (+)3-PPP stimulates pre-
and post-synaptic dopamine receptors (Hjorth, Carlsson, 
Clark, Svensson, Lindberg, Wikstrom, Sanchez, Lindberg, 
Hacksell, Arvidsson, Johansson, & Nilsson, 1983). If 
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dopamine's facilitation of copulatory behaviors results 
from decreased dopamine activity via autoreceptor 
stimulation, then (-)3-PPP should be more effective 
than (+)3-PPP at increasing copulatory behaviors. In 
fact, the opposite is true. Ahlenius and Larsson 
(1984) reported that (+)3-PPP stimulated copulatory 
behavior, whereas (-)3-PPP was without effect. Thus, 
it is unclear at present to what extent the observed 
effects of dopaminergic manipulations on copulatory 
behaviors reflect the relative activation or blockade 
of pre- and post-synaptic dopamine receptors. 
Serotonergic modulation of sexual behavior. 
Whereas increased dopaminergic activity is 
generally considered to increase sexual behavior, 
substantial evidence suggests that increased serotonin 
activity inhibits copulatory behavior. Tagliamonte, 
Tagliamonte, and Gessa (1971) reported that p-
chlorophenylalanine (PCPA), a serotonin synthesis 
inhibitor, increased sexual behavior previously 
inhibited by pargyline, a monoamine oxidase inhibitor. 
Additionally, pargyline increased brain serotonin 
levels to a greater extent than catecholamine levels, 
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suggesting that the increase in serotonin, rather than 
other monoamines, inhibited male sexual behavior. 
Tagliamonte, Tagliamonte, Gessa, and Brodie (1969) 
reported that PCPA increased male-to-male mounting 
behavior in rats. This increase was greatest at the 
time of maximal brain serotonin depletion. Other 
reports have described decreases in ejaculation latency 
(Malmnas, 1973), and postejaculatory interval (Mitler, 
Morden, Levine & Dement, 1972), as well as increased 
number of males mounting (Malmnas & Meyerson, 1971) 
following PCPA administration. Similarly, serotonin 
depletion by the neurotoxin 5,7-DHT decreased 
ejaculation latency, postejaculatory interval, and 
number of intromissions preceding ejaculation in male 
rats (Larsson, Fuxe, Everitt, Holmgren, & Sodersten, 
1978). 
Disruption of serotonin synthesis facilitates 
copulatory behavior. Conversely, elevation of 
serotonin suppresses male sexual behavior. Malmnas 
(1973) reported that administration of 5-HTP, the 
synthesis precursor of serotonin, decreased copulation 
as indexed by a decreased percentage of animals 
mounting and intromitting, as well as an increase in 
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the latency to intromission for animals that did 
copulate. Ahlenius, Larsson, & Svensson (1980) 
administered a subthreshold dose of 5-HTP in 
combination with a serotonin reuptake blocker 
(zimelidine). This drug combination decreased the 
number of animals mounting and increased intromission 
latencies. 
The effects of direct stimulation or blockade of 
serotonin receptors are less consistent and more 
difficult to interpret, probably as a consequence of 
the large number of receptor subtypes and few 
substances that activate or block only a specific 
population of receptors. The serotonin agonist 8-OH-
DPAT facilitates copulatory behaviors as evidenced by a 
decrease in both ejaculation latency and 
postejaculatory refractory period (Ahlenius, Larsson, 
Svensson, Hjorth, Carlsson, Lindberg, Wikstrom, 
Sanchez, Arvidsson, Hacksell, & Nilsson, 1981). As a 
serotonin agonist, 8-OH-DPAT would be expected to 
inhibit male copulatory behavior. Clark, Smith, 
Stefanick, Arneric, Long, and Davidson (1982) reported 
that another serotonin agonist also facilitated 
copulatory behaviors. RDS-127 decreased both 
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ejaculation latency and the number of intromissions 
preceeding ejaculation. 
Serotonin receptors have been classified into two 
major types, designated S-HT^ and S-HT, receptors (see 
Bradley, Engel, Feniuk, Fozard, Humphrey, Middlemiss, 
Mylecharane, Richardson, & Saxena, 1986, for a 
discussion of receptor classification). 5-HTi 
receptors have been further classified as either 5-
HTIA or 5-HTIB receptors. Accumulating evidence suggests 
that activation of S-HT^ facilitates sexual behavior in 
male rats. 
A variety of 5-HTu, receptor agonists facilitate 
copulatory behavior. Fernandez-Guasti, Escalante, 
Hong, and Agmo (1990) reported that the S-HT^ receptor 
agonist indorenate reduced the number of intromissions 
preceding ejaculation in male rats, although a higher 
dose completely inhibited sexual behavior. Similarly, 
RDS-127 and 8-OH-DPAT, selective S-HT* agonists, 
facilitated copulatory behavior, possibly by blockade 
of presynaptic autoreceptors (Ahlenius et al., 1981; 
Clark et al., 1982; 1983). At present, studies of 
serotonin agonists and antagonists are inconclusive and 
difficult to interpret. Most serotonergic agents 
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affect multiple receptor populations and have mixed 
agonist and antagonist properties. In addition, 
serotonin manipulations may interact with central 
noradrenergic systems. Fernandez-Guasti, Hansen, 
Archer and Jonsson (1986) reported that the serotonin 
agonists lisuride and 5-MeODMT (a selective S-HT* 
agonist) reduced the number of intromissions preceding 
ejaculation, and that this copulatory facilitation was 
blocked by administration of the noradrenergic 
neurotoxin DSP-4. Present evidence suggests that 
stimulation of 5-HTin receptors ( autoreceptors ) may 
facilitate male sexual behavior. In general, 
manipulations increasing serotonin activity tend to 
decrease copulatory behavior, and those that decrease 
serotonin activity facilitate copulation. Thus, it is 
likely that the facilitation of sexual behavior by 5-
HTIA receptors reflects a decrease in serotonin 
synthesis or release, rather than a more specific 
regulation of copulatory behavior by these receptors. 
Noradrenergic mpdql^tjpn QÎ. SSxyal feshavifiE. 
Although norepinephrine (NE) has traditionally 
been considered relatively unimportant in the 
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regulation of male sexual behavior (Crowley & Zemlan, 
1981), more recent research has demonstrated that 
manipulations that decrease noradrenergic 
neurotransmission disrupt copulation. Inhibition of NE 
synthesis with dithiocarbamate or electrolytic lesions 
of the locus coeruleus increased mount, intromission, 
and ejaculation latencies, as well as the duration of 
the postejaculatory refractory period (Mcintosh & 
Barfield, 1984). DSP4, an NE neurotoxin, increased the 
postejaculatory refractory period (Hansen, Kohler, & 
Ross, 1982). Drugs acting at NE receptors may 
similarly decrease sexual behavior. Activation of 
alpha-2 adrenergic receptors (presynaptic 
autoreceptors) decreases central NE activity (Kwong, 
Smith, Davidson & Peroutka, 1986). Clark Smith and 
Davidson (1985a) reported that clonidine, an alpha-2 
adrenergic agonist, decreased the number of male rats 
ejaculating, whereas the alpha-1 antagonist prazosin 
increased intromission and ejaculation latencies. 
Thus, decreasing NE activity by stimulating presynaptic 
receptors or blocking postsynaptic receptors disrupted 
copulatory behaviors. 
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Whereas decreased NE activity is associated with a 
suppression of copulatory behaviors, manipulations that 
increase NE activity facilitate sexual behaviors. 
Substantial evidence indicates that yohimbine, an 
alpha-2 adrenergic antagonist, facilitates copulatory 
behaviors. Yohimbine stimulates NE release by blockade 
of presynaptic autoreceptors (Goldberg & Robertson, 
1983). Clark, Smith, and Davidson (1984; 1985a; 1985b; 
also, see Smith & Davidson, 1990) reported that 
yohimbine facilitated copulatory behaviors in male rats 
following penile anesthetization and castration. 
Additionally, yohimbine increased the copulatory 
performance of sexually inexperienced rats and induced 
copulation in sexually inactive rats. Yohimbine also 
facilitated sexual behavior in male rats in which 
sexual behavior had declined due to age. 
Smith, Lee, Schnur and Davidson (1987) examined 
the effects of yohimbine and two other alpha-2 
adrenergic antagonists (idazoxan and imoloxan) on 
copulatory behavior. Yohimbine and idazoxan increased 
the percentage of animals that copulated, and all three 
substances reduced ejaculation latency and 
postejaculatory interval. Sala, Braida, Leone, 
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Calcaterra, Monti, and Gori (1990) reported that 
yohimbine facilitated copulatory behaviors, whether 
administered systemically or intraventricularly. 
Peters, Koch, and Blythe (1988) demonstrated that 
yohimbine facilitated copulatory behaviors in male rats 
in which copulation had been associatively inhibited. 
Thus, considerable evidence documents the facilitory 
effects of alpha-2 adrenergic antagonists on copulatory 
behaviors. 
Cholinergic and GABAeraic modulation of sexual 
behavior. 
In contrast to the transmitter substances 
previously described, little evidence documents 
modulation of male sexual behaviors by cholinergic 
neurotransmission. Soulairac and Soulairac (1975) 
reported decreased intromission frequency, ejaculation 
latency, and postejaculatory refractory period 
following nicotine administration, although motor 
behavior and brain serotonin levels were also affected. 
More recently, it has been reported that the muscarinic 
agonist oxotremorine reduced ejaculation latency and 
number of intromissions preceding ejaculation, at doses 
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lower than those producing locomotor impairment 
(Ahlenius & Larsson, 1985). This copulatory 
facilitation was reversed by scopolamine but not 
methylscopolamine, suggesting that the effects of 
oxotremorine on sexual behavior are mediated by central 
muscarinic receptors. 
Activation of GABA receptors has been associated 
with a decrease in copulatory behavior. Agmo and 
Paredes (1985) reported that systemic administration of 
baclofen (a GABAg agonist) or THIP (a GABA^) agonist 
decreased the number of male rats that mounted or 
intromitted. Whereas stimulation of GABA receptors 
decreased male sexual behavior, GABA antagonists 
facilitated male sexual behaviors. Injections of the 
specific GABA,, antagonist ( + )bicuculine into the medial 
preoptic area decreased the postejaculatory refractory 
period and increased sexual behavior in castrated rats 
given sub-optimal doses of testosterone (Fernandez-
Guasti, Larsson, & Vega-Sanabria, 1986). Bitran, 
Miller, McQuade, Leipheimer, and Sachs (1988) reported 
that intrathecal administration of both GABA* and GABA» 
agonists (baclofen and THIP, respectively) interfered 
with male penile reflexes. Thus, stimulation of either 
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GABA* or GABA» receptors disrupts male copulatory 
behaviors, whereas blockade of GABA* receptors 
facilitates male sexual behaviors. 
Peptidergic modulation of sexual behavior. 
A large volume of recent research has examined the 
role of neuropeptides in the regulation of male sexual 
behavior. Peptides examined include gonadotrophin 
releasing hormone (GnRH), endogenous opiate-like 
substances, oxytocin, neuropeptide Y, substance P, 
cholecystokinin, and others. As with the 
neurotransmitter substances described previously, male 
sexual behaviors may be either facilitated or disrupted 
by a wide range of pharmacological manipulations of 
these substances. 
Gonadotrophin releasing hormone (GnRH), released 
by the hypothalamus, stimulates the release of 
luteinizing hormone and follicle-stimulating hormone 
from the pituitary. In view of its obvious 
significance in reproductive physiology, the role of 
GnRH in the modulation of copulatory behaviors has been 
examined. Moss, Dudley, Foresman, and McCann (1975) 
reported that GnRH reduced intromission and ejaculation 
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latencies in sexually experienced male rats. 
Similarly, Myers and Baum (1980) found that GnRH 
reduced ejaculation latency in castrated male rats 
receiving testosterone replacement. Dorsa and Smith 
(1980) examined the effects of intracranial 
administration of GnRH and found increased mounting 
following penile anesthetization. Thus, GnRh appears 
to have some facilitory effect on male sexual behavior. 
Another peptide with obvious reproductive 
relevance is oxytocin, which stimulates uterine 
contraction and milk production. Administration of 
oxytocin into the internal carotid artery reduced the 
number of intromissions preceding ejaculation 
(Stoneham, Everitt, Hansen, Lightman, & Todd, 1985). 
Arletti, Bazzani, Castelli, and Bertolini (1985) 
reported that a smaller dose, administered 
intraventricularly, reduced ejaculation latency and 
postejaculatory interval. Additionally, copulatory 
behavior was disrupted by administration of the 
oxytocin antagonist d ( CHj ) jTyr (Me )-Orn®-Vasotocin 
(Argiolas, Collu, D'Aquila, Gessa, Melis & Serra, 
1989). Some evidence suggests that oxytocin may 
participate in human male sexual behavior: Tindal 
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(1975) found that plasma oxytocin increased in human 
males following exposure to erotic stimuli. 
Corticotropin releasing factor (CRF) is a 
hypothalamic peptide which regulates the pituitary-
adrenal stress response (Britton & Koob, 1988). CRF 
acts to decrease GnRH secretion in response to stress. 
Sirinathsinghji (1987) reported that CRF administration 
disrupted male copulatory behavior. Intraventricular 
administration of CRF increased mount, intromission and 
ejaculation latencies as well as the number of mounts 
preceding ejaculation. 
Disruption of copulatory behavior by CRF was 
antagonized by naloxone, suggesting an interaction with 
central opioid systems. The inhibitory effects of 
opiates on copulatory behaviors are well known (see 
Pfaus & Gorzalka, 1987, for a review). For example, 
Hughes, Everitt, and Herbert (1990) found that 
intracranial microinjections of beta endorphin 
increased mount, intromission, and ejaculation 
latencies but did not affect appetitive or reward-
related aspects of sexual behavior (e.g., place 
preference or partner preference). Meyerson and 
Terenius (1977) reported a decrease in copulatory 
57 
behavior, as evidenced by fewer males mounting, 
following administration of beta-endorphin. 
Conversely, administration of the opiate antagonist 
naloxone induced copulatory behaviors in sexually 
inactive rats (Gessa, Paglietti & Pellegrini-
Quarantotti, 1979). Administration of opiates, 
however, does not universally decrease copulatory 
behavior. Band and Hull (1990) recently reported that 
microinjections of small quantities of morphine or 
dynorphin into the medial preoptic area decreased both 
ejaculation latency and number of intromissions 
preceding ejaculation. The precise role of opiate 
peptides in the regulation of copulatory behaviors 
remains in question. 
A large body of evidence now documents regulation 
of male sexual behavior by a number of neuropeptides. 
In addition to the results described above, disruption 
of copulatory behavior has been observed for 
neuropeptide Y (Clark, Kalra, & Kalra, 1985) and 
angiotensin II (Clark, 1989). Facilitation of 
copulatory behavior has been observed for substance P 
(Dornan & Malsbury, 1989) and cholecystokinin (Dornan & 
Malsbury, 1989; Pfaus & Phillips, 1987). 
58 
Summary 
Male copulatory behaviors are regulated by complex 
interactions involving, to some extent, all of the 
classical neurotransmitters (dopamine, serotonin, 
acetylcholine, norepinephrine) as well as GABA and a 
number of neuropeptides. No reports exist at present 
of the effects of excitatory amino acids (e.g., 
glutamate) on copulation. That a large number of 
neurochemical systems regulate male sexual behavior 
should not be surprising, considering the biological 
and adaptive significance of these behaviors. It is 
clear, however, that attempts to characterize the 
effects of a given pharmacological manipulation on 
sexual behavior are complicated by the complexity of 
interactions among neurotransmitter systems and 
receptor subpopulations existing within any one 
neurotransmitter system. The development of compounds 
possessing greater selectivity for a particular 
population of receptors may eventually enable the 
assessment of possible unique contributions of specific 




Agmo, À., & Paredes, R. (1985). GABAergic drugs and 
sexual behavior in the male rat. European Journal 
of Pharmacology. 112. 371-378. 
Ahlenius, S., & Larsson, K. (1984). Apomorphine and 
haloperidol induced effects on male rat sexual 
behavior: No evidence for actions due to 
stimulation of central dopamine autoreceptors. 
Pharmacology ^ Biochemistry and Behavior. 21, 463-
466. 
Ahlenius, S., & Larsson, K. (1985). Central 
muscarinic receptors and male rat sexual behavior: 
facilitation by oxotremorine but not arecoline or 
pilocarpine in methscopolamine pretreated animals. 
Psychopharmacology (Berlin^. 87. 127-129. 
Ahlenius, S., Larsson, K., & Svensson, L. (1980). 
Further evidence for an inhibitory role of central 
5-HT in male rat sexual behavior. 
Psvchopharmacology (Berlin^. 68, 217-222. 
Àhlenlus, S., Larsson, K., Svensson, L., Hjorth, S., 
Carlsson, A., Lindberg, P., Wikstrom, H., Sanchez, 
D., Arvidson, L.-E., Hacksell, U., & Nilsson, J. 
L. G. (1981). Effects of a new type of 5-HT 
receptor agonist on male rat sexual behavior. 
Pharmacology. Biochemistry and Behavior. 15, 785-
792. 
Argiolas, A., Collu, M., D'Aquila, P., Cessa, G. L., 
Melis, M. R., & Serra, G. (1989). Apomorphine 
stimulation of male copulatory behavior is 
prevented by the oxytocin antagonist 
d(GHz)sTyr(Me)-Orn®-Vasotocin in rats. 
Pharmacology. Biochemistry and Behavior. 33. 81-
83. 
Arletti, R., Bazzani, C., Castelli, M., & Bertolini, A. 
(1985). Oxytocin improves male copulatory 
performance in rats. Hormones and Behavior. 19, 
14-20. 
Band, L. C., & Hull, E. M. (1990). Morphine and 
dynorphin(l-13) microinjected into the medial 
preoptic are and nucleus accumbens: effects on 
sexual behavior in male rats. Brain Research. 
SM, 77-84. 
Barbeau, À. (1969). L-DOPA therapy in Parkinson's 
disease: A critical review of nine years' 
experience. Canadian Medical Association Journal. 
101. 791-800. 
Bartholini, G., de Prada, M., Pletscher, A. (1968). 
Decrease of cerebral 5-hydroxytryptamine after 
inhibition of extracerebral decarboxylase. 
Journal of Pharmacy and Pharmacology. 20, 228-
229. 
Benkert, O., Crombach, G., & Kockott, G. (1972). 
Effect of L-DOPA on sexually impotent patients. 
Psychopharmacology. 23. 91-95. 
Bitran, D., & Hull, E. M. (1987). Pharmacological 
analysis of male rat sexual behavior. 
Neuroscience and Behavioral Reviews. 11. 365-389. 
Bitran, D., Miller, S. A., McQuade, D. B., Leipheimer, 
R. E., & Sachs, B. D. (1988). Inhibition of 
sexual reflexes by lumbosacral injection of a 
GABAB agonist in the male rat. Pharmacology. 
Biochemistry and Behavior. 31, 657-666. 
62 
Bowers, M. B., van Woert, M., & Davis, L. (1971). 
Sexual behavior during 1-DOPA treatment for 
Parkinsonism. American Journal of Psychiatry. 
127. 1691. 
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., 
Humphrey, P. P. A., Middlemiss, D. N., 
Mylecharane, E. J., Richardson, B. P., & Saxena, 
P. R. (1986). Proposals for the classification 
and nomenclature of functional receptors for 5-
hydroxytrypatamine. Neuropharmacology. 25, 563-
576. 
Britton, K. T., & Koob, G. F. (1988). Behavioral 
effects of corticotropin releasing factor. In 
Schatzberg, A. F., & Nemeroff, C. B. (Eds.), The 
Hypothalamic-Pituitary-Adrenal Axis: Physiology. 
Pathophysiology. and Psychiatric Implications, pp. 
55-66. New York: Raven Press. 
Chambers, K. C., & Phoenix, C. H. (1989). 
Apomorphine, deprenyl, and yohimbine fail to 
increase sexual behavior in rhesus males. 
Behavioral Neuroscience. 103. 816-823. 
Clark, J. T. (1989). A possible role for angiotensin 
II in the regulation of male sexual behavior in 
rats. Physiology and Behavior. 45. 221-246. 
Clark, J. T., Kalra, S. P., & Kalra, P. S. (1985). 
Neuropeptide Y stimulates feeding but inhibits 
sexual behavior in rats. Endocrinology. 115. 
2435-2442. 
Clark, J. T., Smith, E. R., & Davidson, J. M. (1984). 
Enhancement of sexual motivation in male rats by 
yohimbine. Science. 225. 857-849. 
Clark, J. T., Smith, E. R., & Davidson, J. M. (1985a). 
Evidence for the modulation of sexual behavior by 
alpha-adrenoceptors in male rats. 
Neuroendocrinology. 41. 36-43. 
Clark, J. T., Smith, E. R., & Davidson, J. M. (1985b). 
Testosterone is not required for the enhancement 
of sexual motivation by yohimbine. Physiologv and 
Behavior ^ 35, 517-521. 
Clark, J. T., Smith, E. R., Stefanick, M. L., Arneric, 
S. P., Long, J. P., & Davidson, J. M. (1982). 
Effects of a novel dopamine receptor agonist RDS-
127 (2-n, N-di-n-propylamino-4,7-dimethoxindane) 
on hormone levels and sexual behavior in the male 
rat. Physiology and Behavior. 29, 1-6. 
Clark, J. T., Stefanick, M. L., Smith, E. R., & 
Davidson, J. M. (1983). Further studies on 
alterations in male rat copulatory behavior 
induced by the dopamine receptor agonist RDS-127. 
Pharmacology. Biochemistry and Behavior. 19. 781-
786. 
Crowley, W. R., & Zemlan, F. P. (1981). The 
neurochemical control of mating behavior. In N. 
T. Adler (Ed.), Neuroendocrinology of 
Reproduction. (pp. 458-484). New York: Plenum 
Press. 
Dornan, W. A., & Malsbury, C. W. (1989). Peptidergic 
control of male rat sexual behavior: the effects 
of intracerebral injections of substance P and 
cholecystokinin. Physiology and Behavior ^ 46, 
547-556. 
Dorsa, D. M., & Smith, E. R. (1980). Facilitation of 
mounting behavior in male rats by intracranial 
injections of luteinizing hormone-releasing 
hormone. Regulatory Peptides^ 1, 147-155. 
Falaschi, P., Rocco, A., De Giorgio, G., Frajese, G., 
Fratta, W., & Gessa, G. L. (1981). Brain 
dopamine and premature ejaculation: Results of 
treatment with dopamine receptor antagonists. In 
Gessa, G. L., & Corsini, G. U. (Eds.), 
Apomorphine and Other Dopaminomimetics. New York; 
Raven Press. 
Fernandez-Guasti, A., Escalante, A., Hong, E., & Agmo, 
A. (1990). Behavioral actions of the 
serotonergic anxiolytic indorenate. Pharmacology. 
Biochemistry and Behavior. 17, 83-88. 
Fernandez-Guasti, A., Hansen, S., Archer, T., & 
Jonsson, G. (1986). Noradrenaline-serotonin 
interactions in the control of sexual behavior in 
the male rat: DSP4-induced noradrenalin depletion 
antagonizes the facilitory effect of serotonin 
receptor agonists, 5-MeODMT and lisuride. Brain 
Research. 377. 112-118. 
Fernandez-Guasti, A., Larsson, K., & Vega-Sanabria, J. 
(1986). Depression of postejaculatory ultrasonic 
vocalization by (+)bicuculine. Behavioral Brain 
Research. 19, 35-39. 
Gessa, G. L., Paglietti, E., & Pellegrini-Quarantotti, 
B. (1979). Induction of copulatory behavior in 
sexually inactive rats by naloxone. Science. 204. 
203-205. 
Goldberg, M. R., & Robertson, D. (1983). Yohimbine: a 
pharmacological probe for study of the alpha-2 
adrenoceptor. Pharmacological Reviews. 35. 143-
179. 
Gray, G. D., Davis, H. N., & Dewsbury, D. A. (1974). 
Effects of 1-DOPA on the heterosexual copulatory 
behavior of male rats. European Journal of 
Pharmacology. 27, 367-370. 
Guerin, G. F., Doeders, N. E., Dworkin, S. I., & Smith, 
J. E. (1984). Intracranial self-administration 
of dopamine into the nucleus accumbens. Society 
for Neuroscience Abstracts. 10. 1072. 
Hansen, S., Kohler, C., & Ross, S. B. (1982). On the 
role of the dorsal mesencephalic tegmentum in the 
control of masculine sexual behavior in the rat: 
Effects of electrolytic lesion, ibotenic acid and 
DSP4. Brain Research. 240. 311-320. 
Hart, B. L., & Leedy, M. G. (1985). Neurological 
bases of male sexual behavior. In Adler, N., 
Pfaff, D., & Goy, R. W., (Eds.), Handbook o£ 
Behavioral Neurobiology; Reproduction. New York: 
Plenum Press. 
Hjorth, S., Carlsson, A., Clark, D., Svensson, K., 
Lindberg, M., Wikstrom, H., Sanchez, D., Lindberg, 
P., Hacksell, U., Arvidsson, L.-E., Johansson, A., 
& Nilsson, J. L. G. (1983). Central dopamine 
receptor agonist and antagonist actions of the 
enantiomers of 3-PPP. Psychopharmacoloav 
(Berlin). 81, 89-99. 
Hughes, A. M., Everitt, B. J., & Herbert, J. (1990). 
Comparative effects of preoptic area infusions of 
opioid peptides, lesions and castration on sexual 
behaviour in male rats: studies of instrumental 
behaviour, conditioned place preference and 
partner preference. Psychopharmacoloay^ 102. 243-
256. 
Hyppa, M., Lehtinen, P., & Rinne, U. K. (1971). 
Effects of 1-DOPA on hypothalamic, pineal and 
striatal monoamines and on sexual behavior of the 
rat. Brain Research. 30, 265-272. 
Kwong, L. L, Smith, E. R., Davidson, J. M., & Peroutka, 
S. J. (1986). Differential interactions of 
"prosexual" drugs with 5-hydroxytryptamine lA and 
alpha-2 adrenergic receptors. Behavioral 
Neuroscience. 100. 664-668. 
Larsson, K., Fuxe, K., Everitt B. J., Holmgren M., 
Sodersten, P. (1978). Sexual behavior in male 
rats after intracerebral injection of 5,7-
dihydroxytryptamine. Brain Research. 141. 293-
303. 
Malmnas, C. O. (1973). Monoaminergic influence on 
testosterone-activated copulatory behavior in the 
castrated male rat. Acta Physioloaia Scandinavia. 
Supp. 195, 1-128. 
Malmnas, C. O. (1976). The significance of dopamine, 
versus other catecholamines, for 1-DOPA induced 
facilitation of sexual behavior in the castrated 
male rat. Pharmacology. Biochemistry and 
Behavior. 4, 521-526. 
Malmnas, C. O., & Meyerson, B. J. (1971). g-
chlorophenylalanine and copulatory behavior in the 
male rat. Nature. 232. 398-400. 
Mcintosh, T. K., & Barfield, R. J. (1984). Brain 
monoaminergic control of male reproductive 
behavior. III. Norepinephrine and the 
postejaculatory refractory period. Behavioral 
Brain Research. 12., 275-281. 
Meyerson, B. J., & Terenius, L. (1977). Beta-
endorphin and male behavior. European Journal of 
Pharmacoloav. 12, 191-192. 
Mitler, M., Morden, B., Levine, S., & Dement, W. 
(1972). The effects of p-chlorophenylalanine on 
the mating behavior of male rats. Physiology and 
Behavior. 8, 1147-1150. 
Moss, R. L., Dudley, C. À., Foresman, M. M., & McCann, 
S. M. (1975). A potentiator of sexual behavior 
in the rat. In Moss, M., Crosignani, P. G. & 
Martini (Eds.), Hypothalamic Hormone Chemistry. 
Physiology. Pharmacology and Clinical Uses, pp. 
269-278. London; Academic Press. 
Myers, B. M., & Baum, M. J. (1980). Facilitation of 
copulatory performance in male rats by naloxone: 
Effects of hypophysectomy, 17-estradiol and 
luteinizing hormone releasing hormone. 
Pharmacology. Biochemistry and Behavior. 12., 365-
370. 
Paglietti, E., Pellegrini-Quarantotti, B., Mereu, G., & 
Gessa, G. L. (1978). Apomorphine and 1-DOPA 
lower ejaculation threshold in the male rat. 
Physiology and Behavior. 2Û, 559-562. 
Pehek, E. A., Thompson, J. T., & Hull, E. M. (1989). 
The effects of intrathecal administration of the 
dopamine agonist apomorphine on penile reflexes 
and copulation in the male rat. 
Psvchopharmacoloay. 99, 304-308. 
Pehek, E. A., Warner, R. K., Bazzet, T. J., Bitran, D., 
Band, L. C., Eaton, R. C., & Hull, E. M. (1988). 
Microinjection of cis-flupenthixol. a dopamine 
antagonist, into the medial preoptic area impairs 
sexual behavior of male rats. Brain Research. 
443. 1988. 
Peters, R. H., Koch, P. C., & Blythe, B. L. (1988). 
Differential effects of yohimbine and naloxone on 
copulatory behaviors of male rats. Behavioral 
Neuroscience. 102.(4), 559-564. 
Pfaus, J. G., & Gorzalka, B. B. (1987). Opioids and 
sexual behavior. Neuroscience and Biobehavioral 
Reviews. H, 1-34. 
Pfaus, J. G., & Phillips, A. G. (1987). 
Cholecystokinin facilitates ejaculation in male 
rats; blockade with proglumide and apomorphine. 
European of Pharmacoloav. Ml, 331-338. 
Pleiiti, E. T., Matochik, J. A., Barfield, R. J., & 
Auerbach, S. B. (1990). Correlation of dopamine 
release in the nucleus accumbens with masculine 
sexual behavior in male rats. Brain Research. 
524. 160-163. 
Pomerantz, S. M. (1990). Apomorphine facilitates male 
sexual behavior of Rhesus monkeys. Pharmacology. 
Biochemistry and Behavior. 25, 659-664. 
Sala, M., Braida, D., Leone, M. P., Calcaterra, P., 
Monti, S., & Gori, E. (1990). Central effect of 
yohimbine on sexual behavior in the rat. 
Physiology and Behavior. 47, 165-173. 
Sirinathsinghji, D. J. S. (1987). Inhibitory 
influence of corticotropin releasing factor on 
components of sexual behavior in the male rat. 
Brain Research. 407. 185-190. 
Smith, E. R., & Davidson, J. M. (1990). Yohimbine 
attenuates aging-induced sexual deficiencies in 
male rats. Physiology and Behavior. 47, 631-634. 
Smith, E. R., Lee, R. L, Schnur, S. L., & Davidson, J. 
M. (1987). Alphaj-adrenoceptor antagonists and 
male sexual behavior: I. Mating behavior. 
Phvsiology and Behavior. Al, 7-14. 
Soulairac, M.-L., & Soulairac, A. (1975). 
Monoaitiinergic and cholinergic control of sexual 
behavior in the male rat. In Sandler, M., & 
Gessa, G. L. (Eds.), Sexual Behavior; Pharmacology 
and Biochemistry. New York: Raven Press. 
Stellar, J. R., Kelley, A. E., & Corbett, D. (1983). 
Effects of peripheral and central dopamine 
blockade on lateral hypothalamic self^stimulation: 
Evidence for both reward and motor deficits. 
Pharmacology. Biochemistry and Behavior. 18, 433-
442. 
Stoneham, M. D., Everitt, B. J., Hansen, S., Lightman, 
S. L., & Todd, K. (1985). Oxytocin and sexual 
behavior in the male rat and rabbit. Journal o£ 
Endocrinologv. 107, 97-106. 
Tagliamonte, A., Fratta, W., del Fiacco, M., & Gessa, 
G. L. (1974). Possible stimulatory role of brain 
dopamine in the copulatory behavior of male rats. 
Pharmacology. Biochemistry and Behavior. 2, 257-
260 .  
Tagliamonte, À., Tagliamonte, P, & Cessa, G. L. 
(1971). Reversal of pargyline-induced inhibition 
of sexual behavior in male rats by p-
chlorophenylalanine. Nature. 230. 244-245. 
Tagliamonte, A., Tagliamonte, P., Gessa, G. L., & 
Brodie, B. B. (1969). Compulsive sexual activity 
induced by p-chlorophenylalanine in normal and 
pinealectomized male rats. Science. 166. 1433-
1435. 
Tindal, J. S. (1975). Stimuli that cause the release 
of oxytocin. In Geiger, R. (Ed.), Handbook of 
Physiology and Endocrinology. Washington, D. C.: 
American Physiology Association. 
